PRESS RELEASE
24 October 2022

Marks & Clerk’s UPC Call To Action Featured Med-Tech Innovation

MC
Marks & Clerk

Contributor

Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.
It was great to see our call to action to patent holders riding high in the med-tech news pages this morning! According to a roadmap issued earlier this month...
United Kingdom

It was great to see our call to action to patent holders riding high in the med-tech news pages this morning! According to a roadmap issued earlier this month, the Unitary Patent package has a provisional start date of 1 April 2023, meaning patent owners must assess their rights and protections in line with the new package, and take action accordingly. Full details can be found in the article below.

Simon Mounteney, managing partner (Europe) at Marks & Clerk, said: "The new system will offer a significant reduction in costs for innovators who seek protection in more than a handful of EU states as they will no longer have to take parallel action in multiple countries. Likewise, where disputes and patent infringement are an issue, the claimant will only need to commence infringement proceedings in a single court in order to obtain a single pan-European injunction (preliminary or final) across several countries."

www.med-technews.com/...

Contributor

Marks & Clerk is one of the UK’s foremost firms of Patent and Trade Mark Attorneys. Our attorneys and solicitors are wired directly into the UK’s leading business and innovation economies. Alongside this we have offices in 9 international locations covering the EU, Canada and Asia, meaning we offer clients the best possible service locally, nationally and internationally.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More